Literature DB >> 16081772

Cutting edge: a single MHC class Ia is sufficient for CD8 memory T cell differentiation.

Matthew A Williams1, Michael J Bevan.   

Abstract

Recent studies have suggested a role for MHC class Ib molecules in providing signals for memory T cell differentiation during the early phases of acute infection. To test this hypothesis, we assessed the development of effector and memory CD8 T cells in transgenic mice expressing a single chain H-2D(d)/beta2-microglobulin (beta2M) fusion protein on a beta2M-deficient background. These mice thus express a single MHC class Ia in the absence of all other beta2M-dependent class Ia and Ib molecules. Following infection with a recombinant vaccinia virus expressing a known D(d)-restricted epitope from HIV-1 gp160, the development of effector and memory cells CD8 T cells was comparable to control mice. Furthermore, these memory cells responded rapidly and robustly to antigenic restimulation. Therefore, we conclude that full CD8 memory differentiation requires only a single MHC class Ia chain, ruling out a requirement for MHC class Ib molecules in this process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081772      PMCID: PMC2776089          DOI: 10.4049/jimmunol.175.4.2066

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Effector and memory T-cell differentiation: implications for vaccine development.

Authors:  Susan M Kaech; E John Wherry; Raft Ahmed
Journal:  Nat Rev Immunol       Date:  2002-04       Impact factor: 53.106

2.  The crystal structure of a TL/CD8alphaalpha complex at 2.1 A resolution: implications for modulation of T cell activation and memory.

Authors:  Yiwei Liu; Yi Xiong; Olga V Naidenko; Jin-huan Liu; Rongguang Zhang; Andrzej Joachimiak; Mitchell Kronenberg; Hilde Cheroutre; Ellis L Reinherz; Jia-huai Wang
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

3.  CD8alphaalpha-mediated survival and differentiation of CD8 memory T cell precursors.

Authors:  Loui T Madakamutil; Urs Christen; Christopher J Lena; Yiran Wang-Zhu; Antoine Attinger; Monisha Sundarrajan; Wilfried Ellmeier; Matthias G von Herrath; Peter Jensen; Dan R Littman; Hilde Cheroutre
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

4.  Peptide-independent folding and CD8 alpha alpha binding by the nonclassical class I molecule, thymic leukemia antigen.

Authors:  Dominique A Weber; Antoine Attinger; Christopher C Kemball; Jerrod L Wigal; Jan Pohl; Yi Xiong; Ellis L Reinherz; Hilde Cheroutre; Mitchell Kronenberg; Peter E Jensen
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

5.  Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

Authors:  P L Earl; A W Hügin; B Moss
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

6.  Estimating the precursor frequency of naive antigen-specific CD8 T cells.

Authors:  Joseph N Blattman; Rustom Antia; David J D Sourdive; Xiaochi Wang; Susan M Kaech; Kaja Murali-Krishna; John D Altman; Rafi Ahmed
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

7.  A recombinant, soluble, single-chain class I major histocompatibility complex molecule with biological activity.

Authors:  M G Mage; L Lee; R K Ribaudo; M Corr; S Kozlowski; L McHugh; D H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

8.  An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

Authors:  H Takahashi; J Cohen; A Hosmalin; K B Cease; R Houghten; J L Cornette; C DeLisi; B Moss; R N Germain; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

10.  Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells.

Authors:  Matthew A Williams; Michael J Bevan
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

View more
  6 in total

1.  TL we meet again.

Authors:  Cathryn Nagler; Joanna Wroblewska
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

2.  Cutting edge: memory CD8 T cell maturation occurs independently of CD8alphaalpha.

Authors:  Anmol Chandele; Susan M Kaech
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

3.  Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease.

Authors:  Danyvid Olivares-Villagómez; Yanice V Mendez-Fernandez; Vrajesh V Parekh; Saif Lalani; Tiffaney L Vincent; Hilde Cheroutre; Luc Van Kaer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

Review 4.  TL and CD8αα: Enigmatic partners in mucosal immunity.

Authors:  Danyvid Olivares-Villagómez; Luc Van Kaer
Journal:  Immunol Lett       Date:  2010-09-17       Impact factor: 3.685

Review 5.  The role of MHC class Ib-restricted T cells during infection.

Authors:  Courtney K Anderson; Laurent Brossay
Journal:  Immunogenetics       Date:  2016-07-01       Impact factor: 2.846

6.  Mucosal memory CD8⁺ T cells are selected in the periphery by an MHC class I molecule.

Authors:  Yujun Huang; Yunji Park; Yiran Wang-Zhu; Alexandre Larange; Ramon Arens; Iván Bernardo; Danyvid Olivares-Villagómez; Dietmar Herndler-Brandstetter; Ninan Abraham; Beatrix Grubeck-Loebenstein; Stephen P Schoenberger; Luc Van Kaer; Mitchell Kronenberg; Michael A Teitell; Hilde Cheroutre
Journal:  Nat Immunol       Date:  2011-10-02       Impact factor: 25.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.